The present disclosure provides compounds, compositions and method targeting GPER for the treatment of disorders and disease such as cancers, gallstone disease and for neuroprotection. In some aspects, the present disclosure provides compounds of the formula:wherein the variables are as defined herein for the treatment of disease including cancers, hormonal cancers, breast cancers including triple negative breast cancer, and leukemias.
